Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure

被引:47
作者
Mariano-Goulart, D
Eberlé, MC
Boudousq, V
Hejazi-Moughari, A
Piot, C
de Kerleau, CC
Verdier, R
Barge, ML
Comte, F
Bressot, N
Rossi, M
Kotzki, PO
机构
[1] Montpellier Univ Hosp, Dept Nucl Med, F-34295 Montpellier 5, France
[2] Montpellier Univ Hosp, Dept Cardiol B, F-34295 Montpellier 5, France
[3] Montpellier Univ Hosp, Dept Stat & Epidemiol, F-34295 Montpellier 5, France
关键词
right ventricle; ejection fraction; brain natriuretic peptide;
D O I
10.1016/S1388-9842(03)00041-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study sought to investigate whether the presence of right ventricular systolic dysfunction with pre-existing left ventricular systolic dysfunction is associated with higher plasma brain natriuretic peptide (BNP) levels, compared with patients with isolated left ventricular dysfunction. Eighty-five patients referred for evaluation of isotopic ventricular function were prospectively included in the study. Left (LVEF) and right (RVEF) ventricular ejection fractions were evaluated by gated blood pool scintigraphy and compared with plasma BNP levels. BNP correlated negatively with LVEF, except in patients with ischaemic heart disease (P = 0.09) and in patients with LVEF < 40% (P = 0.11). In contrast, BNP levels correlated negatively with RVEF for all subgroups. Among patients with RVEF<40%, no significant BNP difference was found between patients with or without additional left ventricular systolic dysfunction (P = 0.51). Among patients with LVEF < 40%, plasma BNP levels were significantly higher in patients with RVEF < 40% than in patients with RVEF > 40% (P = 0.004) whereas age, renal function, clinical findings, ventricular volumes, LVEF or medication were not significantly different. In conclusion, an important increase in BNP levels in patients with left ventricular systolic dysfunction should be considered by cardiologists as an indication of high risk of right ventricular dysfunction and should justify further investigation. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 77 条
[21]  
Gavazzi A, 1997, J HEART LUNG TRANSPL, V16, P774
[22]   Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure [J].
Ghio, S ;
Gavazzi, A ;
Campana, C ;
Inserra, C ;
Klersy, C ;
Sebastiani, R ;
Arbustini, E ;
Recusani, F ;
Tavazzi, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :183-188
[23]  
Gil V M, 1999, Rev Port Cardiol, V18, P791
[24]  
Groch MW, 2001, J NUCL MED, V42, P1773
[25]   Validation of a knowledge-based boundary detection algorithm: A multicenter study [J].
Groch, MW ;
Erwin, WD ;
Murphy, PH ;
Ali, A ;
Moore, W ;
Ford, P ;
Qian, JZ ;
Barnett, CA ;
Lette, J .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (06) :662-668
[26]  
HASEGAWA K, 1993, AM J PATHOL, V142, P107
[27]   PLASMA BRAIN NATRIURETIC PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE CONCENTRATIONS CORRELATE WITH LEFT-VENTRICULAR END-DIASTOLIC PRESSURE [J].
HAUG, C ;
METZELE, A ;
KOCHS, M ;
HOMBACH, V ;
GRUNERT, A .
CLINICAL CARDIOLOGY, 1993, 16 (07) :553-557
[28]   Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot [J].
Hayabuchi, Y ;
Matsuoka, S ;
Kuroda, Y .
PEDIATRIC CARDIOLOGY, 1999, 20 (05) :343-350
[29]   Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers [J].
Horie, H ;
Tsutamoto, T ;
Ishimoto, N ;
Minai, K ;
Yokohama, H ;
Nozawa, M ;
Izumi, M ;
Takaoka, A ;
Fujita, T ;
Sakamoto, T ;
Kito, O ;
Okamura, H ;
Kinoshita, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (02) :282-290
[30]   Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease [J].
Ishii, J ;
Nomura, M ;
Ito, M ;
Naruse, H ;
Mori, Y ;
Wang, JH ;
Ishikawa, T ;
Kurokawa, H ;
Kondo, T ;
Nagamura, Y ;
Ezaki, K ;
Watanabe, Y ;
Hishida, H .
CLINICA CHIMICA ACTA, 2000, 301 (1-2) :19-30